5-fluorouracil
Adenocarcinoma
anthracycline
anti-PD1 blockade
AT-rich interactive domain 1A
ATM protein; human; carcinoma; neuroendocrine; breast neoplasms
bevacizumab
biosimilar
Bone marrow metastasis
BRAF
Breast cancer; hormone-positive cancer; bone metastasis; CDK4-6 inhibitors
breast neoplasms
Breast radiotherapy; HER-2 positive breast cancer; brain metastasis
castration-sensitive
chemotherapy
corpus callosum
cytoreductive surgery
Cytotoxic lesion
disease free survival
doxorubicin
Ductal carcinoma in situ
early detection
Endometrial neoplasms
epirubicin
epithelioid histology
Febrile neutropenia
filgrastim
FOLFIRI
FOLFOX
G6PD deficiency
health
hemolysis
hyperthermic intraperitoneal chemotherapy
immune checkpoint inhibitor
Immune checkpoint inhibitors
Immune related adverse events; immune checkpoint inhibitors; immunotherapy; neurological adverse events; neurological toxicities
Immunoconjugates; brain neoplasms; brain edema
immunohistochemistry
KRAS
Lung neoplasms; mesenchymal stem cells; interleukin-12; cell cycle proteins
Malignant peritoneal mesothelioma
medical oncology
Medical oncology; medical board exams; large language model; clinical reasoning
metastatic colorectal cancer
microsatellite instability
mismatch repair
mNSCLC
multi-kinase inhibitor
neutropenia
NLR
oncology
oral cancer
oral squamous cell carcinoma
overall survival
pathologic complete response
phosphatase and tensin homolog deleted on chromosome 10
Pleural effusion; chronic myeloid leukemia; blastic transformation
prognosis
prostate cancer
public health initiatives
radiotherapy
Regorafenib
Renal cell carcinoma; axitinib; nivolumab; everolimus
RMH score
secondary malignancy
SII
Stomach neoplasms; body mass index; nutritional status; inflammation; survival
survival rates
Synthetic antigen; E. coli Nissle 1917; colorectal cancer; PD-1/CD28; CAR-T-cells
systemic immune-inflammation index
systemic inflammation
thyroid metastasis
tumor-to-tumor metastasis
Van Nuys prognostic index
